# A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

> **NCT05255458** · PHASE3 · COMPLETED · sponsor: **Akeso** · enrollment: 122 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **BIOLOGICAL:** AK102
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05255458
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-04
- **Primary completion:** 2023-01-09
- **Final completion:** 2023-01-09
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05255458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05255458, "A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05255458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*